enrofloxacin has been researched along with Leukemia, Myeloid, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Efthimiadou, EK; Karaliota, A; Katsarou, ME; Psomas, G; Vourloumis, D | 1 |
1 other study(ies) available for enrofloxacin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Copper; Deoxyribonucleases; DNA, Superhelical; Escherichia coli; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Microbial Sensitivity Tests; Necrosis; Norfloxacin; Organometallic Compounds; Phenanthrolines; Pseudomonas aeruginosa; Staphylococcus aureus | 2008 |